Interpharm Financial Statements From 2010 to 2026

IPAH Stock  USD 0  0.00  0.00%   
Interpharm Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Interpharm Holdings' valuation are provided below:
Gross Profit
12 M
Profit Margin
(0.42)
Market Capitalization
2.1 M
Revenue
69.2 M
Earnings Share
(0.09)
We have found one hundred twenty available fundamental trends for Interpharm Holdings, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Interpharm Holdings regular fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Interpharm Holdings' current Market Cap is estimated to increase to about 795.3 K. The Interpharm Holdings' current Enterprise Value is estimated to increase to about 25.8 M

Interpharm Holdings Total Revenue

56.58 Million

Check Interpharm Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Interpharm Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 9.1 M or Total Revenue of 56.6 M, as well as many indicators such as Price To Sales Ratio of 0.0105, Dividend Yield of 0.16 or PTB Ratio of 0.0696. Interpharm financial statements analysis is a perfect complement when working with Interpharm Holdings Valuation or Volatility modules.
  
Build AI portfolio with Interpharm Stock
Check out the analysis of Interpharm Holdings Correlation against competitors.
For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.

Interpharm Holdings Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets89.8 M85.5 M72.5 M
Slightly volatile
Total Current Liabilities36.9 M35.2 M29.7 M
Slightly volatile
Total Stockholder Equity15.9 M13.1 M11.7 M
Slightly volatile
Accounts Payable18.8 M17.9 M15.1 M
Slightly volatile
Cash61.6 K64.8 K72.7 K
Slightly volatile
Other Assets8.1 M7.7 M6.5 M
Slightly volatile
Inventory20.9 M19.9 M16.8 M
Slightly volatile
Other Current Assets18 K18.9 K110.5 K
Slightly volatile
Total Liabilities56.1 M53.4 M45 M
Slightly volatile
Preferred Stock Total Equity14.8 M14.1 M11.8 M
Slightly volatile
Common Stock795.7 K757.9 K638.4 K
Slightly volatile
Property Plant Equipment41.7 M39.7 M33.2 M
Slightly volatile
Other Liabilities1.6 M1.6 M1.3 M
Slightly volatile
Long Term Debt9.3 M16.7 M13.5 M
Slightly volatile
Net Tangible Assets15.9 M10.2 M12.2 M
Pretty Stable
Net Receivables11.5 M14.9 M12.6 M
Slightly volatile
Short and Long Term Debt14.6 M13.9 M11.6 M
Slightly volatile
Total Current Assets26 M36.9 M31.2 M
Slightly volatile
Short Term Debt14.6 M13.9 M11.6 M
Slightly volatile

Interpharm Holdings Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.1 M15.5 M13.2 M
Very volatile
Total Revenue56.6 M86.9 M74.9 M
Very volatile
Gross Profit26.2 M24.9 M21.5 M
Slightly volatile
Research Development22.9 M21.8 M18.3 M
Slightly volatile
Cost Of Revenue32.4 M48.5 M52.7 M
Slightly volatile
Income Tax Expense118.5 K171 K179.4 K
Very volatile
Total Operating Expenses63.4 M99.3 M82.8 M
Slightly volatile

Interpharm Holdings Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures9.7 M9.2 M7.7 M
Slightly volatile
Change To Liabilities2.9 M2.3 MM
Slightly volatile
Change To Account Receivables1.1 M1.1 M1.4 M
Slightly volatile
Total Cash From Financing Activities25.4 M24.2 M20.2 M
Slightly volatile
Sale Purchase Of Stock544.9 K320.8 K445.5 K
Slightly volatile
Depreciation1.7 M2.8 M2.3 M
Pretty Stable
Dividends Paid146 K111.6 K127.8 K
Slightly volatile
Change To Netincome5.3 M5.1 M4.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.01050.010.0104
Slightly volatile
Dividend Yield0.160.170.1741
Slightly volatile
PTB Ratio0.06960.06630.0687
Slightly volatile
Days Sales Outstanding36.6256.2659.1832
Very volatile
Book Value Per Share0.190.28.0102
Slightly volatile
Average Payables2.4 M2.7 MM
Slightly volatile
Capex To Depreciation1.592.822.8792
Very volatile
PB Ratio0.06960.06630.0687
Slightly volatile
EV To Sales0.340.330.3404
Slightly volatile
Inventory Turnover3.413.594.1011
Slightly volatile
Days Of Inventory On Hand111105110
Slightly volatile
Payables Turnover3.183.343.76
Slightly volatile
Average Inventory4.8 M4.6 M4.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.240.230.2344
Slightly volatile
Capex To Revenue0.10.09530.0988
Slightly volatile
Cash Per Share0.00120.00130.9814
Slightly volatile
Days Payables Outstanding119113118
Slightly volatile
Income Quality0.820.90.9351
Slightly volatile
Intangibles To Total Assets0.170.130.1242
Pretty Stable
Current Ratio2.11.211.1316
Slightly volatile
Tangible Book Value Per Share0.190.22.8632
Slightly volatile
Receivables Turnover10.476.716.3828
Pretty Stable
Shareholders Equity Per Share0.190.28.0102
Slightly volatile
Debt To Equity2.22.092.2054
Slightly volatile
Capex Per Share0.07850.110.115
Very volatile
Average Receivables4.4 M5.8 M6.1 M
Pretty Stable
Revenue Per Share1.271.3373.9012
Slightly volatile
Interest Debt Per Share0.440.475.5357
Slightly volatile
Debt To Assets0.340.320.348
Pretty Stable
Graham Number3.012.622.3628
Slightly volatile
Operating Cycle170162171
Slightly volatile
Price Book Value Ratio0.06960.06630.0687
Slightly volatile
Days Of Payables Outstanding119113118
Slightly volatile
Ebt Per Ebit1.791.491.5153
Slightly volatile
Company Equity Multiplier6.155.866.2192
Slightly volatile
Long Term Debt To Capitalization0.530.50.5277
Slightly volatile
Total Debt To Capitalization0.660.630.675
Slightly volatile
Debt Equity Ratio2.22.092.2054
Slightly volatile
Quick Ratio0.530.560.5168
Slightly volatile
Net Income Per E B T0.630.910.9869
Slightly volatile
Cash Ratio0.00260.00270.0076
Slightly volatile
Cash Conversion Cycle35.1848.6651.5389
Very volatile
Days Of Inventory Outstanding111105110
Slightly volatile
Days Of Sales Outstanding36.6256.2659.1832
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.891.81.5863
Slightly volatile
Price To Book Ratio0.06960.06630.0687
Slightly volatile
Fixed Asset Turnover2.392.5211.7168
Slightly volatile
Debt Ratio0.340.320.348
Pretty Stable
Price Sales Ratio0.01050.010.0104
Slightly volatile
Asset Turnover1.111.171.1868
Slightly volatile
Gross Profit Margin0.270.260.2732
Slightly volatile
Price Fair Value0.06960.06630.0687
Slightly volatile

Interpharm Holdings Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap795.3 K757.5 K784.5 K
Slightly volatile
Enterprise Value25.8 M24.6 M25.6 M
Slightly volatile

About Interpharm Holdings Financial Statements

Investors use fundamental indicators, such as Interpharm Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Interpharm Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue86.9 M56.6 M
Cost Of Revenue48.5 M32.4 M
Research And Ddevelopement To Revenue 0.23  0.24 
Capex To Revenue 0.10  0.10 
Revenue Per Share 1.33  1.27 
Ebit Per Revenue(0.14)(0.16)

Currently Active Assets on Macroaxis

When determining whether Interpharm Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Interpharm Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Interpharm Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Interpharm Holdings Stock:
Check out the analysis of Interpharm Holdings Correlation against competitors.
For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.09)
Revenue Per Share
1.048
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.19)
Return On Equity
(1.17)
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.